A woman who was pregnant with twins through an in vitro procedure at Bundang Cha Women's Hospital visited the obstetrics and gynecology clinic at 21 weeks of pregnancy due to cervical incapacity.

Crinetics Pharma's Paltusotine shows strong Phase 3 results for acromegaly. Click here to find out why CRNX stock is a Buy.

OTTUMWA — Ottumwa Regional Health Center has become the first hospital in Iowa to offer Aquablation therapy, a new robotic-assisted treatment for benign prostatic hyperplasia, the hospital announced ...

UVA Health Culpeper Medical Center’s “aquablation” procedure can offer relief for men.

Iridocorneal endothelial (ICE) syndrome is a rare, irreversibly blinding ocular disorder with an unknown etiology. Lack of targeted effective drugs, inadequate disease prognosis, and high relapse ...

WEATHERFORD – Medical City Weatherford is now the first and only hospital in Parker County to offer robotic-assisted water ...

Our strong fourth quarter performance reflects our continued progress in establishing Focal One Robotic HIFU as a mainstream treatment option for the management of prostate cancer,” said Ryan Rhodes, ...

JP Morgan's survey of endocrinologists finds strong awareness of Crinetics' atumelnant, with positive efficacy impressions.

JPMorgan raised the firm’s price target on Neurocrine (NBIX) to $184 from $183 and keeps an Overweight rating on the shares after surveying 24 ...

Benefits seen for retrograde ejaculation, urinary incontinence, with overall symptom relief and safety similar to that seen with laser surgery ...

Stifel initiates coverage on CRNX, a clinical-stage pharmaceutical company focused on endocrine diseases and tumors.

Teleflex today announced new data highlighting the success of its UroLift benign prostatic hyperplasia (BPH) treatment system ...